Our Recommendations
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex B. Qualitative and economic evidence reports (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex A. Quantitative evidence reports (2025)
- Mpox Continental Preparedness and Response Plan for Africa (2024)
- Tests diagnostiques pour la détection du virus de la variole simienne (orthopoxvirus simien, ou MPXV) (2024)
New Publications
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex B. Qualitative and economic evidence reports (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex A. Quantitative evidence reports (2025)
- WHO guidelines on meningitis diagnosis, treatment and care (2025)
- Infection prevention and control and water sanitation and hygiene in health facilities during mpox disease outbreaks: rapid assessment tool, user guide (2025)
Filter
902
Featured
Recommendations
159
New Publications
241
Language
Document type
No document type
425
Guidelines
133
Training Material
51
Manuals
44
Situation Updates
41
Fact sheets
40
Studies & Reports
38
Online Courses
38
Strategic & Response Plan
30
Infographics
28
Resource Platforms
22
Videos
11
Dashboards/Maps
1
Countries / Regions
Congo, Democratic Republic of
32
Brazil
27
Nigeria
23
Guinea
23
Sierra Leone
21
Africa
21
Liberia
20
Madagascar
20
Latin America and the Carribbean
19
Senegal
18
Burkina Faso
17
Rwanda
16
Global
16
Côte d’Ivoire / Ivory Coast
14
Germany
13
Angola
12
Mozambique
11
Western and Central Europe
11
Russia
11
Mali
11
West and Central Africa
9
India
9
Uganda
8
Indonesia
8
Ghana
7
Syria
7
Ethiopia
7
East and Southern Africa
6
South Africa
6
Somalia
6
Paraguay
5
Portugal
5
Yemen
5
Chad
5
South Sudan
5
Colombia
4
Kenya
4
Togo
4
Burundi
4
Peru
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Argentina
4
Vietnam
4
Sri Lanka
4
China
3
Cameroon
3
Niger
3
Central African Republic
3
Nepal
2
Afghanistan
2
Zimbabwe
2
USA
2
Asia
2
Venezuela
2
Bolivia
2
Bangladesh
2
Serbia
1
Turkey
1
Benin
1
Gambia
1
Iran
1
Kyrgyzstan
1
Philippines
1
Italy
1
Haiti
1
Dominican Republic
1
Guinea-Bissau
1
Croatia
1
Tanzania
1
Saudi Arabia
1
Western Pacific Region
1
Turkmenistan
1
Japan
1
United Kingdom
1
Spain
1
Azerbaijan
1
Bosnia and Herzegovina
1
Sudan
1
Honduras
1
Zambia
1
Ecuador
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Key Resources
149
Clinical Guidelines
147
Countries
105
Public Health
60
Capacity Building
49
Pharmacy & Technologies
33
Women & Child Health
4
Ces recommandations temporaires sont émises à l’intention des États Parties qui font face à une transmission du virus de la mpox (MPXV), y compris, sans que cette liste soit exhaustive, ceux touchés par une transmission communautaire persistante et ceux où l’on observe des groupes de cas o...
This interim operational guide outlines infection prevention, control, and water, sanitation, and hygiene measures for home care and isolation of mpox in resource-limited settings. It focuses on practical strategies to manage and prevent the spread of the virus when persons with mpox are isolated at...
WHO guideline on contact tracing
recommended
This practical guideline establishes definitions for “contact”, “contact person”, “contact tracing” and other associated concepts. It allows for improvement of contact tracing strategies and provides recommendations attempting to answer some, though not all, questions that arose during t...
The rapid assessment tool (RAT) is meant to assess health facilities within mpox-affected areas that have at least one inpatient bed. Depending on time and resources available, certain facilities may be prioritized during an mpox outbreak. The RAT evaluates 16 infection prevention and control (IPC) ...
1 April 2025. Key Facts
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
WHO guidelines on meningitis diagnosis, treatment and care. Web Annex A. Quantitative evidence reports
recommended
New
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
WHO guidelines on meningitis diagnosis, treatment and care. Web Annex B. Qualitative and economic evidence reports
recommended
New
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks
recommended
New
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
On 27 September 2024, the Rwanda Ministry of Health announced the confirmation of Marburg virus disease (MVD). Blood samples taken from people showing symptoms were tested by real-time reverse transcription polymerase chain reaction (RT-PCR) at the National Reference Laboratory of the Rwanda Biomedi...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
Le 14 août, l’Organisation mondiale de la Santé (OMS) déclarait que l’épidémie de variole simienne, dite Mpox, était une « urgence sanitaire internationale », après une flambée des cas en Afrique. Le lendemain, un cas était déclaré en Suède. La branche européenne de l’OMS estime...
The safety of children is a top concern for parents and school authorities in the current mpox outbreak, as those
under 15 face elevated risks, particularly in the hardesthit Northwestern and Eastern regions of the Democratic Republic of the Congo.
Infographic
On 27 September 2024, the Ministry of Health of Rwanda confirmed the country’s first outbreak of Marburg virus disease (MVD), with health-care workers in Kigali particularly affected. While sporadic outbreaks have occurred in various parts of Africa since the first recognized cases in 1967, this o...
La République démocratique du Congo (RDC) mise sur la surveillance communautaire pour mieux riposter à la variole simienne appelée en anglais Mpox. En 2023, plus de 14 000 cas de Mpox ont été détectés. Le pays, avec l’appui de ses partenaires, forme les relais communautaires pour la sensib...
Uganda confirmed the first cases of mpox on 24 July 2024 following the confirmation of two case-patients from Kasese District, Bwera Hospital by the Uganda Virus Research Institute (UVRI) through a routine sentinel surveillance system. Cumulatively, 80 confirmed cases of mpox have been registered.
The tab is the result of a preliminary landscape of therapeutics licensed or under development for Mpox
There has been a global outbreak of mpox since 2022; this outbreak has been caused by the strain of mpox virus called Clade 2 and has affected around 116 countries worldwide. The current surge in cases is being driven by the rapid spread of a different strain – Clade 1b – which is predominantly ...
